Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1705-1715

  Selin, Liisa K ^a   Varga, Steven M ^a   Wong, Iris C ^a   Welsh, Raymond M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Heterologous viruses; Immunopathogenesis; Memory T cells; Protective immunity; Virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; IMMUNOPATHOGENESIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MEMORY CELL; MOUSE; NONHUMAN; PICHINDE ARENAVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINIA VIRUS;

ADIPOSE TISSUE; ANIMALS; FEMALE; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; NECROSIS; PHENOTYPE; PICHINDE VIRUS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRUS DISEASES; VIRUSES;

EID: 0032476684     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1705     Document Type: Article

References (46)

1. Lau, L.L., B.D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature. 369:648-652.
2. Selin, L.K., K. Vergilis, R.M. Welsh, and S.R. Nahill. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489-2499.
3. Selin, L.K., and R.M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J. Immunol. 158:5366-5373.
4. Razvi, E.S., R.M. Welsh, and H.I. McFarland. 1995. In vivo state of antiviral CTL precursors: characterization of a cycling population containing CTL precursors in immune mice. J. Immunol. 154:620-632.
5. Tough, D.F., and J. Sprent. 1994. Turnover of naive-and memory-phenotype T cells. J. Exp. Med. 179:1127-1135.
6. Sprent, J., and D.F. Tough. 1996. Lymphocyte life-span and memory. Science. 265:1395-1400.
7. Akbar, A.N., M. Salmon, and G. Janossy. 1991. The synergy between naive and memory T cells during activation. Immunol. Today. 12:184-188.
8. McFarland, H.I., S.R. Nahill, J.W. Maciaszek, and R.M. Welsh. 1992. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. J. Immunol. 149:1326-1333.
9. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-1375.
10. Andersson, E.G., J.P. Christenson, O. Marker, and A.R. Thomsen. 1994. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J. Immunol. 152:1237-1245.
11. Yang, H., P.L. Dundon, S.R. Nahill, and R.M. Welsh. 1989. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142:1710-1718.
12. Selin, L.K., S.R. Nahill, and R.M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
13. Tabi, Z., F. Lynch, R. Ceredig, J.E. Allan, and P.C. Doherty. 1988. Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol. 113:268-277.
14. Bradley, L.M., M. Croft, and S.L. Swain. 1993. T-cell memory: new perspectives. Immunol. Today. 14:197-199.
15. Tough, D.L., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon. Science. 272:1947-1950.
16. + T cells are hyperactive to antigenic challenge in vitro. J. Exp. Med. 184:2141-2151.
17. Muller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
18. Welsh, R.M., P.W. Lampert, P.A. Burner, and M.B.A. Oldstone. 1976. Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virol. 73:59-71.
19. Welsh, R.M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148: 163-181.
20. Bukowski, J.F., B.A. Woda, S. Habu, K. Okumura, and R.M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131:1531-1538.
21. Tanaka, Y., and S.S. Tevethia. 1988. In vitro selection of SV40 antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J. Immunol. 140:4348-4354.
22. Yang, H., I. Joris, G. Majno, and R.M. Welsh. 1985. Necrosis of adipose tissue induced by sequential infections with unrelated viruses. Am. J. Pathol. 120:173-177.
23. Openshaw, P., E.E. Murphy, N.A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-1367.
24. Nahill, S.R., and R.M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317-327.
25. Rabin, H., R.F. Hopkins III, F.W. Ruscetti, R.H. Neubauer, R.L. Brown, and T.G. Kawakami. 1981. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127:1852-1856.
26. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. J. Immunol. 126: 1614-1619.
27. Pross, H.F., M.G. Baines, P. Rubin, P. Shragge, and M.S. Paterson. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. J. Clin. Immunol. 1:51-63.
28. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
29. Szomolanyi-Tsuda, E., and R.M. Welsh. 1996. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J. Exp. Med. 183:403-411.
30. Welsh, R.M., and G.C. Sen. 1996. Non-specific host responses to viral infections. In Viral Pathogenesis. N. Nathanson, editor. Lippincott-Raven Publishers, New York. 109-142.
31. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
32. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R.M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin-and Fas-dependent cytotoxocity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256-3262.
33. Doherty, P.C., and R.M. Zinkernagel. 1974. T-cell-mediated immunopathology in viral infections. Transplant. Rev. 19:89-120.
34. Cole, G.A., N. Nathanson, and R.A. Prendergast. 1972. Requirement for Φ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 238:335-337.
35. Kapikian, A.Z., R.H. Mitchell, R.M. Chanock, R.A. Shvedoff, and C.E. Stewart. 1969. An epidemiological study of altered clinical reactivity to respiratory syncitial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
36. Cannon, M.J., P.J.M. Openshaw, and B.A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
37. Graham, B.S., L.A. Bunton, P.F. Wright, and D.T. Karzon. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026-1033.
38. Anderson, R.W., J.R. Bennick, J.W. Yewdell, W.L. Maloy, and J.E. Coligan. 1992. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Mol. Immunol. 29:1089-1096.
39. Shimojo, N., W.L. Maloy, R.W. Anderson, W.E. Biddison, and J.E. Coligan. 1989. Specificity of peptide binding by the HLA-A2.1 molecule. J. Immunol. 143:2939-2947.
40. d-restricted, influenza specific CTL clone. Mol. Immunol. 28:1-7.
41. Fazekas de St. Groth, S., and R.G. Webster. 1966. Disquisitions on original antigenic sin II. Proof in lower creatures. J. Exp. Med. 124:347-361.
42. Ehl, S., J. Hombach, P. Aichele, H. Hengartner, and R.M. Zinkernagel. 1997. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 185:1241-1251.
43. Zarozinski, C.C., and R.M. Welsh. 1997. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 185:1629-1639.
44. Weinstein, L., and R.H. Meade. 1956. Respiratory manifestations of chickenpox. Arch. Intern. Med. 98:91-99.
45. Rickinson, A.B., and E. Kieff. 1996. Epstein-Barr virus. In Virology Volume 2. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.S. Straus, editors. Lippincott-Raven Publishers, Philadelphia. 2397-2446.
46. Evans, C.F., M.S. Horwitz, M.V. Hobbs, and M.B.A. Oldstone. 1996. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. Med. 184:2371-2384.